频繁献血者的克隆性血液形成景观
Darja Karpova1,2,3,4,5, Hector Huerga Encabo6, Elisa Donato1,2,3
1Division of Stem Cells and Cancer, German Cancer Research Center, Heidelberg, Germany.
Blood
|March 11, 2025
概括
频繁献血不会增加克隆性血液形成 (CH) 的发生率. 然而,红色素 (EPO) 选择性地促进了在捐赠者体内具有特定DNMT3A突变的造血干细胞 (HSC) 的生长,揭示了新的进化压力.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 献血至关重要,但其对供体造血干细胞 (HSC) 和克隆造血 (CH) 的长期影响还未得到充分研究.
- 复发性神经切除术可能会对HSC施加选择性压力,可能会影响CH的发展.
研究的目的:
- 研究大量献血对频繁献血者 (FD) 的CH发病率和HSC突变模式的影响.
- 在模仿失血的条件下,探索高细胞中特定DNMT3A突变的功能后果.
主要方法:
- 对217名老年男性频繁捐献者 (>100次捐献) 和212名零星捐献者进行CH的查.
- 深度测序DNMT3A突变,并使用CRISPR编辑的人类HSC进行功能分析.
- 单细胞剖析和异种移植模型,以评估在红色受体应激下血统偏差和分化.
主要成果:
- 频繁和零星捐赠者之间整体CH发生率没有显著差异.
- 在频繁捐献者中观察到明显的DNMT3A突变模式.
- 红色素 (EPO) 选择性地促进具有特定DNMT3A变异的HSC的脱落,与响应干扰素gamma的白血病原R882突变不同.
- 对EPO敏感的HSC在人造压力下表现出偏好的红状腺分化,没有观察到髓状腺偏差.
结论:
- 广泛的献血不会增加CH发病率,但会塑造HSC中的DNMT3A突变模式.
- 环氧化作为一种新型的环境因素,有利于特定的DNMT3A突变HSC的扩张,特别是在人造压力下.
- 研究结果揭示了正在进行的体质干细胞进化,受血液损失的生理反应的影响.
相关概念视频
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K
Bone Marrow Sampling and Transplants
270
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
270
Overview of Hematopoiesis
3.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.7K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Production of Formed Elements
1.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


